Selection from HEOR Bibliography
| Search criteria | ||||
| England |
||||
| CO71 Investigating the Secondary Care System Burden of Glycogen Storage Disease Type IA (GSDIA) Using the HES Database | ||||
| E Kruger S Chavda RN Gupta V Valayannopoulos | ||||
| Ultragenyx Pharmaceutical Inc., Novato, CA, USA IQVIA, London, UK Ultragenyx Pharmaceutical Inc., Cambridge, MA, USA | ||||
| Kruger, E et al. Value in Health, Volume 25, Issue 7, S317 |
||||
| , Abstract, Article | ||||
| , England | ||||
| Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(22)00370-9/pdf#%20 | ||||
| Condition | Year | Language | Analysis type | |
| , Metabolic Disorders , Rare disease, Rare Diseases | 2022 | English | , Burden of illness, clinical setting: Secondary care, Quality of life | |
| English demographics and cost of HIV-associated comorbidities in individuals over the age of 35: an investigation using the Hospital Episode Statistics (HES) database | ||||
| Wild L, Smith A, Sathia L, Davies S, Fernandez DP, Lawrence D. | ||||
| 1Gilead Sciences, London, UK, 2IQVIA, London, UK | ||||
| HIV MEDICINE 2018 Apr 1 (Vol. 19, pp. S76-S77). |
||||
| , Abstract, Poster | ||||
| , England | ||||
| Abstract: https://onlinelibrary.wiley.com/doi/10.1111/hiv.12614 | ||||
| Condition | Year | Language | Analysis type | |
| , HIV AIDS | 2022 | English | , Cost consequence, Cost of illness, Database Study, Population Based Study | |
| POSB392 Understanding the Secondary Care Characteristics and Pathways of Multiple Myeloma Patients Who Reach Second-Line Therapy Using the Hospital Episode Statistics (HES) Database | ||||
| E Mary Babu S Fermahan S Chavda M Chetty S Navani A Matthew R Hudson | ||||
| Sanofi, Reading, RDG, UK IQVIA, London, UK | ||||
| Mary Babu, E et al. Value in Health, Volume 25, Issue 1, S257 |
||||
| , Abstract, Article | ||||
| , England | ||||
| Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(21)03050-3/fulltext#%20 | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2022 | English | , Burden of illness, clinical setting: Secondary care, Database Study, Population Based Study, Retrospective database analysis | |
| Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database | ||||
| C. Hopkins - S. Conlon - S. Chavda - R. Hudson - R. Rout | ||||
| Guy's and St. Thomas' Hospital, Kings college, London, UK. Sanofi Genzyme UK, Reading, UK. IQVIA, London, UK. | ||||
| Rhinology 60-4: 252-260, 2022 |
||||
| , Article | ||||
| , England | ||||
| Abstract: https://www.rhinologyjournal.com/Abstract.php?id=2979 | ||||
| Condition | Year | Language | Analysis type | |
| , Respiratory disease, Surgery | 2022 | English | , Budget impact, Burden of illness, Cost analysis, Retrospective database analysis | |
| Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension | ||||
| Allan Lawrie 1 2, Neil Hamilton 3, Steven Wood 2 4, Fernando Exposto 5, Ruvimbo Muzwidzwa 5, Louise Raiteri 5, Amélie Beaudet 6, Audrey Muller 6, Rafael Sauter 6, Nadia Pillai 6, David G Kiely | ||||
| National Heart and Lung Institute, Imperial College London London UK. 2Insigneo Institute for In-Silico Medicine University of Sheffield Sheffield UK. 3Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital Sheffield UK. 4Scientific Computing, Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital Sheffield UK. 5IQVIA London UK. 6Actelion Pharmaceuticals Ltd. Allschwil Switzerland. 7Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK. | ||||
| Pulm Circ. 2022 Oct; 12(4): e12136. Published online 2022 Sep 30. doi: 10.1002/pul2.12136 |
||||
| , Article | ||||
| , England | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525996/ | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2022 | English | , Observational study, Retrospective cohort analysis | |
| PRS72 DRUG TREATMENT PATTERNS FOR PULMONARY ARTERIAL HYPERTENSION PATIENTS IN ENGLAND: A RETROSPECTIVE ANALYSIS USING HOSPITAL TREATMENT INSIGHTS DATABASE | ||||
| A. Beaudet A. Yesufu-Udechuku E.W. Davies L.H. Taylor S. Sikander-Rehman R. Ogley F. Exposto | ||||
| Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland Actelion Pharmaceuticals UK Ltd, London, UK Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland IQVIA, London, UK | ||||
| Open ArchiveDOI:https://doi.org/10.1016/j.jval.2019.09.2561 |
||||
| , Poster | ||||
| , England | ||||
| Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34939-3/fulltext | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Drug safety, Drug Utlization Study, Health status & patient reported outcomes | 2019 | English | , Public Health, Real World Data, Retrospective cohort analysis, Retrospective Field Study | |
| Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension | ||||
| David G. Kiely,1,2,3 Orla Doyle,4 Edmund Drage,4 Harvey Jenner,4 Valentina Salvatelli,4 Flora A. Daniels,4 John Rigg,4 Claude Schmitt,5 Yevgeniy Samyshkin,5 Allan Lawrie,2,3,* and Rito Bergemann6,* | ||||
| Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK 2Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK 3INSIGNEO, University of Sheffield, Sheffield, UK 4Real-World & Analytical Solutions, IQVIA, London, UK 5GSK, Middlesex, UK 6Evalueserve UK Ltd, London, UK David G. Kiely, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK. Email: ten.shn@1yleik.divad Allan Lawrie, Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK | ||||
| Pulm Circ. 2019 Oct-Dec; 9(4): 2045894019890549. Published online 2019 Nov 20. doi: 10.1177/2045894019890549 |
||||
| , Article | ||||
| , England | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868581/ | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2019 | English | , Machine Learning/Artificial Intelligence | |
| Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care | ||||
| David R M Smith,F Christiaan K Dolk, Koen B Pouwels, Morag Christie, Julie V Robotham, Timo Smieszek | ||||
| Public Health England | ||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Miscellaneous | 2018 | English | , Retrospective database analysis | |
| Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care | ||||
| Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Julie V Robotham, Timo Smieszek | ||||
| Public Health England | ||||
| , Article, Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Miscellaneous | 2018 | English | , Retrospective database analysis | |
| Explaining variation in antibiotic prescribing between general practices in the UK | ||||
| Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
| Public Health England | ||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| 2018 | English | |||
| Explaining variation in antibiotic prescribing between general practices in the UK | ||||
| Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
| Public Health England | ||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| 2018 | English | |||
| Explaining variation in antibiotic prescribing between general practices in the UK | ||||
| Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
| Public Health England | ||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| 2018 | English | |||
| Explaining variation in antibiotic prescribing between general practices in the UK | ||||
| Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham | ||||
| Public Health England | ||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| 2018 | English | |||
| Potential for reducing inappropriate antibiotic prescribing in English primary care | ||||
| Timo Smieszek, Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Susan Hopkins, Mike Sharland, Alastair D Hay, Michael V Moore, Julie V Robotham | ||||
| Public Health England | ||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Miscellaneous | 2018 | English | , Retrospective database analysis | |
| Chapter 4.1 Drug Utilisation and Prescription-Event Monitoring | ||||
| Massoud Toussi and Deborah Layton | ||||
| IQVIA, Cedex France; IQVIA, London | ||||
| , Book chapter | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Drug Utlization Study | 2018 | English | , Epidemiological study | |
| #2811 Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study | ||||
| Jens Benn Sørensen, Simon Ekman, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarez‐Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun, Maria Planck | ||||
| Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium; Department of Oncology, Radiumhospitalet, Oslo, Norway; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden | ||||
| , Poster | ||||
| , England, Nordic, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | , Retrospective cohort analysis | |
| Feasibility Analysis and Data Visualization to Identify a Complex Group of Cancer in the Simulacrum | ||||
| ALI ABBASI1,2, Shubham Tayal3, Deborah Layton1 and Toby Gosden1 | ||||
| 1IQVIA, LONDON, United Kingdom2University Medical Centre Groningen, Groningen, Netherlands3IQVIA, Gurgaon, India | ||||
| , Poster | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | , Epidemiological study | |
| Treatment patterns in patients with stage IIIB-IV NSCLC in clinical practice: Retrospective analysis of a UK trust database | ||||
| Michael Snee, Sue Cheeseman, Matthew Thompson, Laure Lacoin, Will Sopwith, Paul Godden, Carlos Chaib, Melinda Daumont, John R. Penrod, John O’Donnell & Geoff Hall | ||||
| The Leeds Teaching Hospitals NHS Trust, Leeds/United Kingdom; IQVIA, London/United Kingdom; Bristol-Myers Squibb, Braine L’Alleud/Belgium; Bristol-Myers Squibb, Madrid/Spain; Bristol-Myers Squibb, Princeton, New Jersey/United States of America | ||||
| , Poster | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | , Retrospective database analysis | |
| High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project | ||||
| Rito Bergemann 1 2, James Allsopp 3, Harvey Jenner 4, Flora Ashley Daniels 4, Edmund Drage 4, Yevgeniy Samyshkin 1, Claude Schmitt 1, Steven Wood 3 5, David G Kiely 5 6 7, Allan Lawrie 5 7; SPHInX Project team | ||||
| 1 GlaxoSmithKline, Brentford, Middlesex, UK. 22 Current affiliation: Evalueserve Life Sciences Healthcare, London, UK. 33 Scientific Computing Group, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK. 44 IQVIA, London, UK. 55 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. 66 National Pulmonary Hypertension Service (Sheffield), Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, UK. 77 INSIGNEO, University of Sheffield, Sheffield, UK. | ||||
| Pulm Circ. 2018 Oct-Dec; 8(4): 2045894018798613. Published online 2018 Sep 6. doi: 10.1177/2045894018798613 |
||||
| , Article | ||||
| , England | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/30187824/ | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2018 | English | , Population Based Study | |
| "Real-world incidence of Nd:YAG laser capsulotomy over 3 years following cataract surgery among hydrophobic and hydrophilic acrylic monofocal intra-ocular lenses (IOLs) " | ||||
| Paul G Ursell, Mukesh Dhariwal, Michael S Keith, Katarina Majirska, Frank Ender, Christine Bouchet, Cristiana Miglio and Sarah Rabhi | ||||
| Epsom & St Helier University Hospitals NHS Trust, Alcon Eye Care Limited, Novartis, IQVIA | ||||
| , Oral presentation | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Ophthalmology | 2017 | English | , Retrospective database analysis | |
| Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom. | ||||
| Feher, M., Vega-Hernandez, G., Mocevic, E., Buysse, B., Myland, M., Power, GS | ||||
| Chelsea and Westminster Hospital; IQVIA London | ||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2017 | English | , Epidemiological study | |
| Parents’ expressed emotion and mood, rather than their physical disability are associated with adolescent adjustment: A longitudinal study of families with a parent with multiple sclerosis | ||||
| A Bogosian 1, J Hadwin 2, M Hankins 3, R Moss-Morris 4 | ||||
| 1 Psychology Department, City University, UK 2 Psychology Department, Southampton University, UK 3 Real-World Evidence Solutions, IMS Health, UK 4 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, | ||||
| Clin Rehabil. 2015 Apr 14 |
||||
| , Article | ||||
| , England, Europe | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25872520 | ||||
| Condition | Year | Language | Analysis type | |
| , Musculoskeletal disease, Neurological disorders, Oncology | 2015 | English | , Longitudinal study | |
| Development and psychometric evaluation of a new patient-reported outcome measure for stroke self-management: The Southampton Stroke Self-Management Questionnaire (SSSMQ) | ||||
| Boger EJ1, Hankins M2, Demain SH3, Latter SM4. | ||||
| 1Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK. 2Real-World Evidence Solutions, IMS Health, London, N1 9JY, UK. 3Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK.4Faculty of Health Sciences, University of Southampton | ||||
| Health and Quality of Life Outcomes |
||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Methodology, Oncology, Pain | 2015 | English | , Database Study, Quality of life | |
| Exploring innovative methods to identify patient subgroup treatment response | ||||
| J Rigg, M Hankins, A Roddam, A Avorn, J Kim | ||||
| 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 22-26, 2015. Hynes Convention Center Boston, MA USA. |
||||
| , Conference | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Medication compliance, Methodology | 2015 | English | , Methodology, Observational study | |
| Reducing and quantifying over-fitting in regression models | ||||
| John Rigg, Matthew Hankins | ||||
| IMS Health, London, UK | ||||
| ISPOR 20th Annual International Meeting, May 16 - 20 2015, Philadelphia, PA USA |
||||
| , Conference | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Methodology | 2015 | English | ||
| Real-world Assessment of Renal Involvement in Tuberous Sclerosis Complex (TSC) Patients in the United Kingdom (UK): A Retrospective Cohort Study in the Clinical Practice Research Datalink (CPRD) | ||||
| Kingswood, Chris1, Nasuti, Paola2, Demuth, Dirk2, Patel, Keyur2, Myland, Melissa2, Erhard, Clement3, Gray, Elizabeth4, Pinnegar, Alun4, Magestro, Matthew5 | ||||
| The Royal Sussex County Hospital, Brighton, England 2 IMS Health, London, UK 3 CE Analytics, Cambridge, UK 4 Novartis Pharmaceuticals UK Ltd, Frimley, UK 5 Novartis Pharmaceuticals Corporation, East Hanover NJ, USA | ||||
| International TSC Research Conference (Windsor, 11th Sept 2015). |
||||
| , Poster | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology, Pediatrics, Rare disease | 2015 | English | , Retrospective cohort analysis | |
| DISPENSING FREQUENCY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH RITUXIMAB IN ENGLAND | ||||
| Tsoumani E1, McCann E1, Tham R2, Yu E2 | ||||
| 1MSD, Hoddesdon, UK, 2IMS Health, London, UK | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
| , Poster | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| 2015 | English | |||
| The impact of patient factors on use of antifungal medicines in adults with life-threatening illness: a cross-sectional study in 34 English hospitals | ||||
| Stephens P12, Chikh K1, Leufkens H2 | ||||
| 1IMS HEALTH, London, UK 2 WHO Collaborating Centre for Pharmacoepidemiology and Pharmaceutical Policy Analysis,Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands | ||||
| European Journal of Hospital Pharmacy, 2014; 0:1-8 |
||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Miscellaneous | 2014 | English | , Epidemiological study | |
| Prescribing of antipsychotics in people with dementia in acute general hospitals in England: 2010–2012 | ||||
| Stephens P12, Chikh K1, Leufkens H2 | ||||
| 1 IMS Health, London, UK 2 WHO Collaborating Centre for Pharmacoepidemiology and Pharmaceutical Policy Analysis, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands | ||||
| European Geriatric Medicine, 5: 394-398 |
||||
| , Article | ||||
| , England | ||||
| Condition | Year | Language | Analysis type | |
| , Neurological disorders | 2014 | English | , Epidemiological study | |